“Usage of bone replacement products not only differs between the US and EU but also among EU countries,” reports Sharon O’Reilly, President and CEO of BioMedGPS. “For example, human-derived products—demineralized bone matrix, structural allografts and stem cells—are widely used in the US whereas synthetics are favored among EU surgeons owing to attitudes toward cadaver tissue in some countries. Spine is typically the largest application for bone replacement products, but in Germany where products are not reimbursed for fusion, the largest application is trauma.”

BioMedGPS analysts—all former competitive intelligence specialists at major orthopedic and spine companies— monitor more than 120 companies and 300 bone replacement products world-wide making SmartTRAK Bone Module the most comprehensive source for up-to-date information on the competitors, emerging products and market developments in this crowded market.

Currently available SmartTRAK modules include:

OrthoBiologics

Extremities (Foot & Ankle, Wrist & Hand, Shoulder)

Spine (Fusion, Motion, Spinous Process Implants, VCF)

Wound Biologics

This fall, BioMedGPS will be launching SmartTRAK modules for:

Hip and Knee Replacement

Sports Medicine Fixation

Advanced Dressings, Negative Pressure Wound Therapy

SmartTRAK transforms business intelligence into an accessible enterprise-wide process, gives companies power to upload and share their insights onto the platform securely, and provides powerful tools facilitating strategic analysis. See what subscribers have to say about SmartTRAK by visiting http://biomedgps.com/intro.

About BioMedGPS, LLC

BioMedGPS, LLC provides online business intelligence and dynamic decision-making tools specifically for life science executives. BioMedGPS is led by Sharon O’Reilly, founder and former President & CEO of Medtech Insight.